Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Acta Neuropathologica

• Publication date

  2006-05-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-006-0037-0PMID 16718349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Local neuroinflammation and the progression of Alzheimer’s disease

  2011cited by this paper
• Brain aging in acquired immunodeficiency syndrome: Increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation

  2011cited by this paper
• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection

  2011cited by this paper
• Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers

  2005cited by this paper
• Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

  2005cited by this paper
• Influence of HAART on HIV-related CNS disease and neuroinflammation.

  2005cited by this paper
• Highly Active Antiretroviral Therapy Improves Neurocognitive Functioning

  2004cited by this paper
• Neuropsychiatric impact of hepatitis C on advanced HIV

  2004cited by this paper
• Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART

  2004cited by this paper
• The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease.

  2004cited by this paper
• Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.

  2004cited by this paper
• Antiretroviral therapy in HIV infection: are neurologically active drugs important?

  2004cited by this paper
• Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon

  2004cited by this paper
• The Changing Pattern of HIV Neuropathology in the HAART Era

  2003cited by this paper
• The Neuropathology of HIV Infection in the Era of Highly Active AntiRetroviral Therapy (HAART)

  2003cited by this paper
• Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

  2003cited by this paper
• Assessing the Efficacy of Highly Active Antiretroviral Therapy in the Brain

  2003cited by this paper
• Tau aggregation in the hippocampal formation: an ageing or a pathological process?

  2002cited by this paper
• Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease

  2002cited by this paper
• Insights into the role of immune activation in HIV neuropathogenesis

  2002cited by this paper
• Explaining neurocognitive aging: is one factor enough?

  2002cited by this paper
• Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

  2001cited by this paper
• Evidence for a cerebral effect of the hepatitis C virus.

  2001cited by this paper
• Macrophages and HIV-1-associated dementia.

  2000cited by this paper
• Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia

  2000cited by this paper
• Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine

  2000cited by this paper
• Macrophages and HIV-1-associated dementia.

  2000cited by this paper
• Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.

  1999cited by this paper
• Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

  1999cited by this paper
• Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

  1999cited by this paper
• Prevalence of Alzheimer plaques in AIDS

  1998cited by this paper
• The neuropathology of adult HIV infection.

  1998cited by this paper
• The neuropathology of adult HIV infection.

  1998cited by this paper
• Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease

  1996cited by this paper
• Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports.

  1996cited by this paper
• Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

  1996cited by this paper
• Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia

  1995cited by this paper
• AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic

  1991cited by this paper
• Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

  1989cited by this paper
• AIDS dementia complex.

  1988cited by this paper
• The AIDS dementia complex.

  1988cited by this paper
• The AIDS dementia complex: II. Neuropathology

  1986cited by this paper
• The AIDS dementia complex: I. Clinical features

  1986cited by this paper
• Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau.

  1986cited by this paper
• Tubulin requires tau for growth onto microtubule initiating sites.

  1976cited by this paper

• Implications of virus-induced stress granules in tauopathies

  2026cites this paper
• Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder

  2025cites this paper
• Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV

  2025cites this paper
• Amyloid-β PET Positivity Among Cognitively Impaired People with HIV Over Age 60.

  2025cites this paper
• The Impact of HIV on Early Brain Aging—A Pathophysiological (Re)View

  2024cites this paper
• ROS Chronicles in HIV Infection: Genesis of Oxidative Stress, Associated Pathologies, and Therapeutic Strategies

  2024cites this paper
• Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function

  2023cites this paper
• CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV

  2023cites this paper
• Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection

  2023cites this paper
• Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials

  2023cites this paper
• HIV and FIV glycoproteins increase cellular tau pathology via cGMP-dependent kinase II activation

  2022influential citation
• Pet Imaging Reveals Reduced Synaptic Density In People With Well-Controlled Hiv Infection

  2022influential citation
• Association of apolipoprotein E epsilon 4 and cognitive impairment in adults living with human immunodeficiency virus: a meta-analysis

  2022cites this paper
• Alterations of gray and white matter volumes and cortical thickness in treated HIV-positive patients.

  2022cites this paper
• Viruses in neurodegenerative diseases: More than just suspects in crimes

  2022cites this paper
• Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice

  2022cites this paper
• The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism

  2022cites this paper
• Signatures of somatosensory cortical dysfunction in Alzheimer’s disease and HIV-associated neurocognitive disorder

  2022cites this paper
• Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine

  2022cites this paper
• Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis

  2022influential citation
• Neuropathologic Findings in Elderly HIV-Positive Individuals.

  2022cites this paper
• Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration

  2022cites this paper
• Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure

  2022cites this paper
• Impact of HIV-associated cognitive impairment on functional independence, frailty and quality of life in the modern era: a meta-analysis

  2022cites this paper
• A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer’s disease

  2022cites this paper
• Therapeutic Strategies for Tauopathies and Drug Repurposing as a Potential Approach.

  2022cites this paper
• Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: a pharmacokinetic and pharmacodynamic perspective.

  2022cites this paper
• CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study

  2022cites this paper
• Classification of diseases with accumulation of Tau protein

  2022cites this paper
• Neuroimaging Advances in Diagnosis and Differentiation of HIV, Comorbidities, and Aging in the cART Era.

  2021cites this paper
• The struggle of a good friend getting old: cellular senescence in viral responses and therapy

  2021cites this paper
• Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV

  2021cites this paper
• Role of Melatonin on Virus-Induced Neuropathogenesis—A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection

  2021cites this paper
• Impact of HIV-Associated Cognitive Impairment/Functioning On Functional Independence, Frailty And Quality of Life In The Modern Era: A Systematic Review With Meta-Analysis

  2021cites this paper
• Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy.

  2021cites this paper
• PET imaging in HIV patients

  2021cites this paper
• Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders

  2021cites this paper
• Evaluation of Role of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Alzheimer's Disease

  2021cites this paper
• Microbial Infections Are a Risk Factor for Neurodegenerative Diseases

  2021cites this paper
• Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31

  2020cites this paper
• Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy.

  2020cites this paper
• Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1 infected patients.

  2020cites this paper
• An Infectious Origin of Alzheimer’s Disease: An End for This Devastating Disorder?

  2020cites this paper
• Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies

  2020influential citation
• Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders.

  2020cites this paper
• Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice.

  2020influential citation
• Independent and Correlated Role of Apolipoprotein E ɛ4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer’s Disease

  2020cites this paper
• The far-reaching HAND of cART: cART effects on astrocytes

  2020cites this paper
• The impact of HIV central nervous system persistence on pathogenesis.

  2019cites this paper
• Global HIV neurology: a comprehensive review

  2019cites this paper
• Diagnostic and prognostic biomarkers for HAND

  2019cites this paper
• Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

  2019cites this paper
• The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

  2019influential citation
• Pathogenesis of age-related HIV neurodegeneration

  2019cites this paper
• HIV–AIDS: The Neurologic and Cognitive Consequences of HIV-1 Infection

  2019cites this paper
• Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND)

  2019cites this paper
• Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults

  2019cites this paper
• Risk of developing cerebral β-amyloid plaques with post-translational modification among HIV-infected adults.

  2019cites this paper
• Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury

  2019cites this paper
• Smaller limbic structures are associated with greater immunosuppression in over 1000 HIV-infected adults across five continents: Findings from the ENIGMA-HIV Working Group

  2019cites this paper
• Alzheimer’s disease neuropathology may not predict functional impairment in HIV: a report of two individuals

  2018cites this paper
• HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

  2018cites this paper
• HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β2-Microglobulin a Missing Piece of the Pathogenetic Puzzle?

  2018cites this paper
• Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics

  2018cites this paper
• Global developments in HIV neurology.

  2018cites this paper
• Association of antiretroviral therapy with brain aging changes among HIV-infected adults

  2018cites this paper
• HIV-associated neurocognitive disorder.

  2018cites this paper
• Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease

  2018cites this paper
• Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

  2018cites this paper
• HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity

  2017cites this paper
• HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.

  2017cites this paper
• An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

  2017cites this paper
• Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV

  2017cites this paper
• HIV/neuroAIDS biomarkers

  2017cites this paper
• Dysregulation of PINCH signaling in mesial temporal epilepsy.

  2017influential citation
• Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

  2017cites this paper
• Measuring and managing cognitive impairment in HIV.

  2017cites this paper
• Brief Report: Low-Dose Hydrocortisone Has Acute Enhancing Effects on Verbal Learning in HIV-Infected Men

  2017cites this paper
• Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats

  2017cites this paper
• Neuropathology of HIV-1 Disease

  2017cites this paper
• Substratos neuropatológicos das alterações do sistema nervoso central relacionadas à infecção pelo HIV

  2016cites this paper
• HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117

  2016cites this paper
• Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation

  2016cites this paper
• Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview

  2016cites this paper
• CELL INJURY , REPAIR , AGING , AND APOPTOSIS HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via b-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation

  2016cites this paper
• Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics

  2016influential citation
• Prion Diseases, HIV-1 Associated Neurocognitive Disorders, and Alzheimer’s Disease: Implications for Protein Misfolding

  2015cites this paper
• A novel role for and potential therapeutic targeting of heme oxygenase-1 in HIV neuropathogenesis

  2015cites this paper
• Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease

  2015cites this paper
• HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?

  2015influential citation
• Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?.

  2015cites this paper
• Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

  2015cites this paper
• Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.

  2014cites this paper
• Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus

  2014cites this paper
• Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment

  2014cites this paper
• Cerebrospinal Fluid (CSF) Neuronal Biomarkers across the Spectrum of HIV Infection: Hierarchy of Injury and Detection

  2014cites this paper
• Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV.

  2014cites this paper
• HIV Infection, Neurological Complications of

  2014cites this paper
• Degradation of the Oncoprotein Mdmx in Neurodegenerative States: Evidence for a Pro-Survival Role of Mdmx in Neurons

  2014cites this paper
• The role of tau protein in HIV-associated neurocognitive disorders

  2014influential citation